Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Palladium Metallicum
Generic Name
Palladium Metallicum
Active Ingredient
PalladiumCategory
Standardized Chemical Allergen [EPC]
Variants
9
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_C]/1 | PELLET | ORAL | 37662-1992 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-1993 |
| 10 [hp_M]/1 | PELLET | ORAL | 37662-1999 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Palladium Metallicum, you must consult a qualified healthcare professional.
| 30 [hp_C]/1 | PELLET | ORAL | 37662-1994 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-1996 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-1995 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-1998 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-2000 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-1997 |
Detailed information about Palladium Metallicum
Palladium is a transition metal primarily utilized in clinical medicine as a standardized chemical allergen for diagnostic patch testing. It belongs to the class of acetylcholine release inhibitors and is frequently associated with cross-sensitivity to nickel.
For diagnostic purposes, Palladium is administered as part of a patch test series. The standard dosage for adults involves the application of a minute amount of Palladium Sodium Dichloride (1.0% to 2.0% in petrolatum). This is typically applied using a specialized delivery system (such as the T.R.U.E. Test or Finn Chambers) to the upper back. The dose is not measured in milligrams per kilogram but rather in the concentration of the allergen per unit area of the patch.
In the context of dental use, the amount of palladium is determined by the specific alloy requirements for the prosthetic device, often ranging from 10% to 80% of the total alloy weight.
While patch testing with Palladium is performed in children, it is generally reserved for those with a high suspicion of metal allergy (e.g., reactions to ear piercings or dental braces). There is no standardized 'pediatric dose'; however, clinicians may use a lower concentration (e.g., 0.5% or 1.0%) to minimize the risk of a 'false positive' or an overly aggressive inflammatory reaction in the thinner skin of younger children. The use of Palladium-103 in pediatric oncology is extremely rare and highly specialized.
No dosage adjustment is required for topical diagnostic patch testing in patients with renal impairment, as systemic absorption is minimal. However, for patients with chronic exposure to palladium (e.g., from extensive dental work), monitoring of renal function may be considered, as the kidneys are a primary site of accumulation for heavy metals.
Similar to renal impairment, topical application does not require adjustment. Systemic palladium is processed by the liver and excreted in bile; therefore, patients with severe hepatic dysfunction should be monitored for signs of metal accumulation if they have internal palladium-containing devices.
Elderly patients may have thinner skin (atrophic skin), which can increase the rate of absorption and the intensity of the reaction during patch testing. Healthcare providers may adjust the duration of patch application or the concentration used.
As a diagnostic agent, Palladium is applied by a healthcare professional, usually a dermatologist or allergist. The process follows these steps:
Storage: Diagnostic palladium patches should be stored in a cool, dry place (refrigeration at 2°C to 8°C is often required for certain formulations) and protected from light.
In diagnostic testing, a 'missed dose' refers to the patch falling off or being removed prematurely. If the patch is removed before the 48-hour mark, the test results may be invalid. Patients should contact their clinic immediately to determine if the test needs to be restarted.
Systemic overdose from topical Palladium is virtually impossible. However, an 'overdose' in the context of patch testing manifests as a 'Hyper-irritable Skin' (Angry Back Syndrome), where the patient reacts strongly to all substances on the test panel due to extreme skin sensitivity. Signs of localized 'overdose' (excessive reaction) include:
In the event of an accidental ingestion of palladium salts, emergency measures include gastric lavage and the administration of chelating agents (such as penicillamine), though these protocols are based on general heavy metal toxicity management.
> Important: Follow your healthcare provider's dosing and application instructions. Do not attempt to perform patch testing or adjust dental materials without professional medical guidance.
Because Palladium is primarily used as a diagnostic allergen, the most common side effects are localized to the site of application. These include:
Palladium should only be used under the supervision of a qualified healthcare professional. Its primary risk is the induction of severe localized or systemic allergic reactions. Patients with a known 'nickel allergy' must be particularly cautious, as there is a high rate of cross-reactivity between nickel and palladium due to their similar electronic configurations and atomic radii.
No FDA black box warnings for Palladium. It is considered safe for its intended diagnostic and prosthetic uses when administered by professionals.
There are no absolute drug-drug contraindications that would result in life-threatening toxicity when Palladium is used topically. However, the following are contraindicated for the validity of the test:
There are no adequate and well-controlled studies of Palladium in pregnant women. Animal reproduction studies have not been conducted with palladium salts. It is unknown whether topical application of palladium sodium dichloride can cause fetal harm. Therefore, Palladium patch testing should be performed during pregnancy only if the potential benefit justifies the potential risk to the fetus. Most dermatologists recommend delaying elective patch testing until the postpartum period.
It is not known whether palladium ions are excreted in human milk following topical application. Because systemic absorption from a diagnostic patch is extremely low, the risk to the nursing infant is considered minimal. However, as a precaution, the patch should not be applied to the breast area to avoid direct contact between the infant's skin/mouth and the allergen.
Palladium is not FDA-approved for use in children under the age of 18 as a standardized allergen, though it is used 'off-label' in pediatric dermatology. In children, the immune system is still developing, and the risk of 'active sensitization' (causing a new allergy by performing the test) is slightly higher than in adults. Dosing adjustments (lower concentrations) are often employed by pediatric specialists.
As a Standardized Chemical Allergen, Palladium acts as a hapten. It is too small to be recognized by the immune system on its own. It must bind to endogenous proteins (like albumin or keratin) to form a hapten-protein complex. This complex is then internalized by Langerhans cells, which migrate to local lymph nodes and present the antigen to naive T-cells, leading to the creation of 'memory T-cells.' Upon re-exposure, these memory cells trigger a localized inflammatory response.
As an Acetylcholine Release Inhibitor [MoA], Palladium ions (Pd2+) act as calcium channel antagonists at the presynaptic membrane. By inhibiting the influx of Ca2+ through voltage-gated channels, Palladium prevents the calcium-dependent phosphorylation of synapsins, which is necessary for moving synaptic vesicles to the active zone. This results in a decrease in the frequency and amplitude of end-plate potentials (EPPs) at the neuromuscular junction.
Common questions about Palladium Metallicum
In clinical medicine, Palladium is primarily used as a diagnostic tool in the form of a patch test to identify allergic contact dermatitis. It is also a common component in dental alloys for crowns and bridges due to its durability and resistance to corrosion. Additionally, the radioactive isotope Palladium-103 is used in brachytherapy to treat certain types of cancer, such as prostate cancer. In research, it is studied as an acetylcholine release inhibitor, which means it can interfere with nerve-to-muscle signaling. Most patients encounter it when being tested for metal allergies or when receiving dental restorations.
The most common side effects are localized to the area where the patch was applied, including redness, intense itching, and small raised bumps. These symptoms are actually signs of a positive reaction, indicating that the patient is likely allergic to the metal. In some cases, small blisters may form if the allergy is severe. These localized symptoms usually appear 48 to 72 hours after application and can last for one to two weeks. Systemic side effects, such as a full-body rash, are extremely rare during diagnostic testing.
There is no direct chemical interaction between alcohol and the Palladium used in patch tests or dental work. However, alcohol consumption can cause blood vessels in the skin to dilate, which might theoretically make the itching or redness of a positive patch test more uncomfortable. It is generally best to avoid excessive alcohol during the 48 to 96 hours of a patch test to ensure the skin remains in a stable state for accurate reading. Always follow the specific lifestyle restrictions provided by your dermatologist during the testing period.
Palladium is classified as FDA Pregnancy Category C, meaning there is insufficient data to confirm its safety during pregnancy. While the amount of palladium absorbed through a skin patch is very small, most healthcare providers recommend delaying elective diagnostic testing until after delivery. This precaution prevents any unnecessary immune system stress or potential systemic inflammation during fetal development. If palladium is already present in your body (such as in dental work), it is generally considered safe to leave it in place, as the release of ions is negligible. Discuss any concerns with your OB-GYN and dermatologist.
Palladium testing relies on a delayed-type hypersensitivity reaction, which takes time to develop. The patch must typically stay on the skin for 48 hours before the first evaluation by a doctor. However, many people do not show a reaction until 72 or 96 hours after the initial application, and some 'late reactors' may not show signs for up to a week. This is why multiple appointments are necessary for an accurate diagnosis. If you are being treated with Palladium-103 for cancer, the radiation effect begins immediately upon implantation and continues for several weeks.
In the context of an allergy, 'stopping' Palladium means removing the source of exposure, such as jewelry or dental work. There is no 'withdrawal' syndrome associated with removing palladium, but your symptoms (like a rash or mouth sores) may take several weeks to fully resolve as the immune system settles down. If you have a palladium-containing medical implant, you should never attempt to have it removed without a thorough evaluation by a specialist. If the 'exposure' is a diagnostic patch, your doctor will remove it at the scheduled time; removing it early may make the test results invalid.
Since Palladium is not a daily medication, a 'missed dose' usually refers to a diagnostic patch falling off or being removed too early. If this happens, you should not try to reattach it yourself with household tape, as this can contaminate the site. Instead, contact your dermatologist's office immediately to see if the test can still be read or if it needs to be rescheduled. For Palladium-103 brachytherapy, the 'dose' is a one-time surgical implantation, so missed doses are not applicable in the traditional sense. Always keep your follow-up appointments for patch test readings.
There is no clinical evidence to suggest that Palladium, whether used in diagnostic testing, dental alloys, or medical implants, causes weight gain. It does not affect the metabolic hormones or caloric balance of the body. If you experience weight changes while being treated for a condition where palladium is used (such as cancer treatment or systemic dermatitis), it is likely due to other factors, such as related medications (like oral steroids) or the underlying health condition itself. Always discuss unexpected weight changes with your healthcare provider.
Palladium patch testing can be affected by other medications, particularly those that suppress the immune system. Systemic steroids like prednisone, or topical steroids applied to the back, can cause a 'false negative' result by preventing the allergic reaction from showing. Most other common medications for blood pressure, cholesterol, or diabetes do not interact with palladium. However, you should always provide your doctor with a full list of your current medications, including herbal supplements, before undergoing any diagnostic testing or surgical procedures involving palladium alloys.
Palladium is an elemental metal, so it does not have a 'brand' or 'generic' version in the way that manufactured drugs do. However, the standardized patches used for testing are produced by different medical supply companies. For dental work, different manufacturers produce various palladium-based alloys, but these are selected by the dental laboratory based on the required physical properties rather than a brand name. If you are diagnosed with a palladium allergy, your doctor will advise you to avoid all forms of the metal, regardless of the manufacturer or the specific alloy name.
> Warning: Stop taking Palladium (or remove the source of exposure) and call your doctor immediately if you experience any of these:
Prolonged exposure to Palladium, particularly through dental alloys or occupational handling, can lead to:
No FDA black box warnings are currently issued for Palladium as a standardized chemical allergen. However, clinicians are cautioned regarding the use of Palladium-103 isotopes in brachytherapy, which carries risks of radiation-induced tissue damage and secondary malignancies, though these are specific to the radioactive form and not the chemical allergen itself.
Report any unusual symptoms or persistent skin changes to your healthcare provider immediately.
Topical application of Palladium for diagnostic purposes does not impair the ability to drive or operate machinery. However, if a patient experiences a severe systemic reaction or intense itching that causes significant distraction, caution is advised.
There are no known direct interactions between alcohol and topical Palladium. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically intensify the itching or redness of a positive patch test reaction.
In the context of diagnostic testing, 'discontinuation' involves the removal of the patch. If a patient is found to be allergic to Palladium, the 'discontinuation' of the allergen involves removing the source of exposure. This may mean:
> Important: Discuss all your medical conditions, especially existing skin conditions and known metal allergies, with your healthcare provider before starting Palladium testing.
Mechanism of Interaction: Most interactions with Palladium are pharmacodynamic (affecting the body's response to the drug) rather than pharmacokinetic (affecting how the body processes the drug). The primary mechanism is the suppression of the T-lymphocyte response by corticosteroids or UV light.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including any creams or ointments you use on your skin.
> Important: Your healthcare provider will evaluate your complete medical history, including all previous allergic reactions, before prescribing or applying Palladium.
In patients over 65, the skin's immune response (delayed hypersensitivity) may be diminished due to 'immunosenescence.' This can result in weaker positive reactions that are harder to read. Additionally, elderly patients are more likely to be taking multiple medications (polypharmacy) that could interfere with test results. Renal function should be considered if systemic exposure is a concern, as GFR naturally declines with age.
For patients with significant renal impairment (Stage 4 or 5 Chronic Kidney Disease), the clearance of any systemically absorbed palladium ions will be reduced. While topical testing is safe, these patients should avoid long-term exposure to palladium-containing internal devices if possible, as the kidneys are a target organ for heavy metal accumulation.
No specific dose adjustments are needed for hepatic impairment in diagnostic testing. In cases of systemic toxicity, the liver's ability to conjugate palladium with glutathione may be compromised, potentially increasing the half-life of the metal in the body. Monitoring of liver function tests (LFTs) is recommended in cases of chronic industrial exposure.
> Important: Special populations require individualized medical assessment and a careful risk-benefit analysis by a specialist.
| Parameter | Value |
|---|---|
| Bioavailability | <0.1% (Topical); <1% (Oral) |
| Protein Binding | >95% (Primarily Albumin) |
| Half-life | 5–12 days (Systemic) |
| Tmax | 48–72 hours (Local reaction) |
| Metabolism | None (Elemental/Ion) |
| Excretion | Renal (70%), Fecal (30%) |
Palladium is a member of the Standardized Chemical Allergen [EPC] class. It is grouped with other metallic allergens such as Nickel Sulfate, Cobalt Chloride, and Potassium Dichromate. Within its neuropharmacological context, it is an Acetylcholine Release Inhibitor, similar in theoretical mechanism (though not clinical use) to botulinum toxins or certain aminoglycoside antibiotics.